INFbeta therapy for COVID-19 the new SNG001 drug /

INFbeta therapy for COVID-19 the new SNG001 drug /

Show other versions (1)
Saved in:
Bibliographic Details
Other Authors: Holgate, S. T. (Speaker)
Format: Electronic Audio
Language:English
Published: London : Henry Stewart Talks, 2020.
Series:Henry Stewart talks. Biomedical & life sciences collection. Interviews on Covid-19.
Subjects:
Antiviral agents > Development.
Clinical trials.
Coronavirus infections > Chemotherapy.
COVID-19 (Disease) > Treatment.
Interferon.
Antiviral Agents > administration & dosage.
Clinical Trials as Topic.
Coronavirus infections.
COVID-19 > drug therapy.
Drug Delivery Systems.
Interferon-beta > administration & dosage.
Interferon-beta > therapeutic use.
Nebulizers and Vaporizers.
SARS-CoV-2.
Treatment Outcome.
Online Access:https://hstalks.com/bs/4301
Series
Tags: Add Tag
No Tags, Be the first to tag this record!
Table of Contents:
  • Contents: Why INFβ was chosen as a therapy for COVID-19
  • Previous use of INFβ by inhalation
  • Safety of INFβ as a therapy
  • SNG001 mode of delivery
  • SNG001 clinical trials and future prospects.

Similar Items